Tag: Michelle Janelsins
Newest data links inflammation to chemo-brain
Chemo-brain, or cancer-related cognitive impairment, is estimated to impact 80 percent of people in treatment. A new Medical Center study shows that inflammation in the blood plays a key role.
Chemo-brain among women with breast cancer is pervasive, study shows
The largest study to date of memory and cognition problems related to chemotherapy shows that women with breast cancer report substantial issues lasting as long as six months after treatment.
Wilmot Cancer Institute researcher wins $2.3M award
Brain biologist Michelle Janelsins is a recipient of the five-year NIH grant as a winner of the 2014 NIH Directors New Innovators Award. She is one of 49 young research scientists nationally to win the prize.